Page 8 - Flipbook
P. 8
The PD-L1 biomarker consists of many different
biomarkers and should be considered as such.
Randomized trials testing PD-L1 in UC
Drug setting Result
atezolizumab Platinum -ve
refractory
atezolizumab Adjuvant -ve
st
Durvalumab 1 line -ve
st
Pembrolizumab 1 line -ve
nivolumab adjuvant +ve for ITT and
PD-L1+ve
st
Avelumab 1 line +ve for ITT and
maintenance PD-L1+ve
